PremiumCompany AnnouncementsCyclacel Pharmaceuticals Announces Reverse Stock Split Cyclacel Pharmaceuticals announces 1-for-16 reverse stock split Cyclacel Pharmaceuticals Enters Share Exchange Agreement PremiumCompany AnnouncementsCyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift Cyclacel Pharmaceuticals Delays 10-K Filing PremiumCompany AnnouncementsCyclacel Pharmaceuticals Restructures Leadership and Financial Strategy Cyclacel announces agreement for acquisition of preferred stock Cyclacel Pharmaceuticals Reports Q3 2024 Financial Results